Key Points
-
Gene targeting of chromosomal sequences by homologous recombination is a powerful method for gene correction that can eliminate dominant mutations causing genetic disease. In mammalian cells, this process is inefficient and much effort is directed towards improving the targeting frequency of conventional plasmid systems, which is only 10−6.
-
The discovery that recombinant adeno-associated virus (rAAV) can introduce precise, site-specific modification in the mammalian genome with a frequency of 1% constituted a major breakthrough in the gene-targeting field.
-
This review discusses the unique features of the rAAV system that are responsible for the high targeting efficiency as well as its successful application in gene therapy.
-
Along with the ability to infect multiple cell types from several different species, rAAV can introduce different types of modifications with high fidelity in both exogenously introduced target genes and endogenous genes.
-
The single-stranded viral genome with inverted terminal repeats is a distinct feature of rAAV that probably mediates the recognition of the genome by appropriate cellular factors and its ability to recombine with homologous sequences in the host genome.
-
On the basis of current knowledge, we propose a mechanism of homologous recombination of the rAAV with the chromosomal target.
-
Understanding the mechanism of rAAV-mediated targeting will improve our ability to manipulate the cellular pathways governing this phenomenon and broaden the scope for practical applications.
Abstract
Vectors based on the adeno-associated virus (AAV) have attracted much attention as potent gene-delivery vehicles, mainly because of the persistence of this non-pathogenic virus in the host cell and its sustainable therapeutic gene expression. However, virus infection can be accompanied by potentially mutagenic random vector integration into the genome. A novel approach to AAV-mediated gene therapy based on gene targeting through homologous recombination allows efficient, high-fidelity, non-mutagenic gene repair in a host cell.
Similar content being viewed by others
References
Baum, C. et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101, 2099–2114 (2003).
Lu, Y. Recombinant adeno-associated virus as delivery vector for gene therapy — a review. Stem Cells Dev. 13, 133–145 (2004).
McCarty, D. M., Young, S. M. Jr. & Samulski, R. J. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 38, 819–845 (2004).
Hacein-Bey-Abina, S. et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255–256 (2003).
Thomas, K. R. & Capecchi, M. R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503–512 (1987).
Deng, C. & Capecchi, M. R. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Mol. Cell. Biol. 12, 3365–3371 (1992).
Jasin, M. Chromosome breaks and genomic instability. Cancer Invest. 18, 78–86 (2000).
Torres, R. M. & Kühn, R. Laboratory Protocols for Conditional Gene Targeting (Oxford Uninversity Press, Oxford, 1997).
McClarrinon, M. et al. In vivo studies of gene expression via transient transgenesis using lipid-DNA delivery. DNA Cell Biol. 18, 533–547 (1999).
Xiang, J. J. et al. IONP-PLL: a novel non-viral vector for efficient gene delivery. J. Gene Med. 5, 803–817 (2003).
Rouet, P., Smih, F. & Jasin, M. Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc. Natl Acad. Sci. USA 91, 6064–6068 (1994).
Brenneman, M., Gimble, F. S. & Wilson, J. H. Stimulation of intrachromosomal homologous recombination in human cells by electroporation with site-specific endonucleases. Proc. Natl Acad. Sci. USA 93, 3608–3612 (1996).
Bibikova, M. et al. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol. Cell. Biol. 21, 289–297 (2001).
Porteus, M. H. & Baltimore, D. Chimeric nucleases stimulate gene targeting in human cells. Science 300, 763 (2003).
Bibikova, M., Beumer, K., Trautman, J. K. & Carroll, D. Enhancing gene targeting with designed zinc finger nucleases. Science 300, 764 (2003).
Epinat, J. C. et al. A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells. Nucleic Acids Res. 31, 2952–2962 (2003).
Fujita, A., Sakagami, K., Kanegae, Y., Saito, I. & Kobayashi, I. Gene targeting with a replication-defective adenovirus vector. J. Virol. 69, 6180–6190 (1995).
Thevenot, E. et al. Targeting conditional gene modification into the serotonin neurons of the dorsal raphe nucleus by viral delivery of the Cre recombinase. Mol. Cell. Neurosci. 24, 139–147 (2003).
Russell, D. W. & Hirata, R. K. Human gene targeting by viral vectors. Nature Genet. 18, 325–330 (1998). The seminal paper that first showed high frequencies of gene targeting by rAAV.
Flierl, A., Chen, Y., Coskun, P. E., Samulski, R. J. & Wallace, D. C. Adeno-associated virus-mediated gene transfer of the heart/muscle adenine nucleotide translocator (ANT) in mouse. Gene Ther. 12, 570–578 (2005).
Bertran, J. et al. Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors. J. Virol. 70, 6759–6766 (1996).
Nakai, H., Storm, T. A. & Kay, M. A. Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo. J. Virol. 74, 9451–9463 (2000).
Nakai, H. et al. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 75, 6969–6976 (2001).
Nakai, H. et al. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nature Genet. 34, 297–302 (2003).
Nakai, H. et al. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J. Virol. 79, 3606–3614 (2005).
Miller, D. G., Rutledge, E. A. & Russell, D. W. Chromosomal effects of adeno-associated virus vector integration. Nature Genet. 30, 147–148 (2002).
Linden, R. M., Ward, P., Giraud, C., Winocour, E. & Berns, K. I. Site-specific integration by adeno-associated virus. Proc. Natl Acad. Sci. USA 93, 11288–11294 (1996).
Samulski, R. J. et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10, 3941–3950 (1991).
Kotin, R. M., Linden, R. M. & Berns, K. I. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11, 5071–5078 (1992).
Schmidt, M., Afione, S. & Kotin, R. M. Adeno-associated virus type 2 Rep78 induces apoptosis through caspase activation independently of p53. J. Virol. 74, 9441–9450 (2000).
Tan, M., Qing, K., Zhou, S., Yoder, M. C. & Srivastava, A. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human β-globin gene in hematopoietic cells from homozygous β-thalassemic mice. Mol. Ther. 3, 940–946 (2001).
Muzyczka, N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97–129 (1992).
Duan, D. et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72, 8568–8577 (1998).
Yan, Z., Zhang, Y., Duan, D. & Engelhardt, J. F. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl. Acad. Sci. USA 97, 6716–6721 (2000).
Duan, D., Yue, Y. & Engelhardt, J. F. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol. Ther. 4, 383–391 (2001).
Goncalves, M. A., Pau, M. G., de Vries, A. A. & Valerio, D. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors. Virology 288, 236–246 (2001).
Chao, H., Sun, L., Bruce, A., Xiao, X. & Walsh, C. E. Expression of human factor VIII by splicing between dimerized AAV vectors. Mol. Ther. 5, 716–722 (2002).
Reich, S. J. et al. Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy. Hum. Gene Ther. 14, 37–44 (2003).
Ellis, J. & Bernstein, A. Gene targeting with retroviral vectors: recombination by gene conversion into regions of nonhomology. Mol. Cell. Biol. 9, 1621–1627 (1989).
Liu, X. et al. Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions. J. Virol. 78, 4165–4175 (2004). Compared gene targeting between the HEK293 cell line and primary mouse fibroblasts, revealing the importance of the natural AAV host. Narrowed down the occurrence of targeting to the S phase of the cell cycle.
Qing, K. et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nature Med. 5, 71–77 (1999).
Hansen, J., Qing, K., Kwon, H. J., Mah, C. & Srivastava, A. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J. Virol. 74, 992–996 (2000).
Hendrie, P. C., Hirata, R. K. & Russell, D. W. Chromosomal integration and homologous gene targeting by replication-incompetent vectors based on the autonomous parvovirus minute virus of mice. J. Virol. 77, 13136–13145 (2003).
Hirata, R. K. & Russell, D. W. Design and packaging of adeno-associated virus gene targeting vectors. J. Virol. 74, 4612–4620 (2000). This study attempts to define the minimal stretch of homology necessary for efficient targeting and proves the importance of single-stranded rather than double-stranded vector genomes.
Russell, D. W., Miller, A. D. & Alexander, I. E. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl Acad. Sci. USA 91, 8915–8919 (1994).
Miller, D. G., Petek, L. M. & Russell, D. W. Adeno-associated virus vectors integrate at chromosome breakage sites. Nature Genet. 36, 767–773 (2004).
Alexander, I. E., Russell, D. W. & Miller, A. D. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68, 8282–8287 (1994).
Russell, D. W., Alexander, I. E. & Miller, A. D. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl Acad. Sci. USA 92, 5719–5723 (1995).
Trobridge, G., Hirata, R. K. & Russell, D. W. Gene targeting by adeno-associated virus vectors is cell-cycle dependent. Hum. Gene Ther. 16, 522–526 (2005).
Saleh-Gohari, N. & Helleday, T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res. 32, 3683–3688 (2004).
Yamamoto, A. et al. Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells. Mol. Gen. Genet. 251, 1–12 (1996).
Chen, F. et al. Cell cycle-dependent protein expression of mammalian homologs of yeast DNA double-strand break repair genes Rad51 and Rad52. Mutat. Res. 384, 205–211 (1997).
Hinz, J. M., Yamada, N. A., Salazar, E. P., Tebbs, R. S. & Thompson, L. H. Influence of double-strand-break repair pathways on radiosensitivity throughout the cell cycle in CHO cells. DNA Repair (Amst.) 4, 782–792 (2005).
Inoue, N., Hirata, R. K. & Russell, D. W. High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors. J. Virol. 73, 7376–7380 (1999).
Brown, P. O. Integration of retroviral DNA. Curr. Top. Microbiol. Immunol. 157, 19–48 (1990).
Inoue, N., Dong, R., Hirata, R. K. & Russell, D. W. Introduction of single base substitutions at homologous chromosomal sequences by adeno-associated virus vectors. Mol. Ther. 3, 526–530 (2001). Expands the types of mutation introduced by rAAV targeting vectors to single nucleotide substitutions, indicating the involvement of base-excision repair in the process.
Hirata, R., Chamberlain, J., Dong, R. & Russell, D. W. Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nature Biotechnol. 20, 735–738 (2002). Pilot study showing high frequency of ex vivo targeted disruption of a dominant negative allele of the COL1A1 gene that causes OI.
Smih, F., Rouet, P., Romanienko, P. J. & Jasin, M. Double-strand breaks at the target locus stimulate gene targeting in embryonic stem cells. Nucleic Acids Res. 23, 5012–5019 (1995).
Sargent, R. G., Brenneman, M. A. & Wilson, J. H. Repair of site-specific double-strand breaks in a mammalian chromosome by homologous and illegitimate recombination. Mol. Cell. Biol. 17, 267–277 (1997).
Taghian, D. G. & Nickoloff, J. A. Chromosomal double-strand breaks induce gene conversion at high frequency in mammalian cells. Mol. Cell. Biol. 17, 6386–6393 (1997).
Essers, J. et al. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell 89, 195–204 (1997).
Rijkers, T. et al. Targeted inactivation of mouse RAD52 reduces homologous recombination but not resistance to ionizing radiation. Mol. Cell. Biol. 18, 6423–6429 (1998).
Miller, D. G., Petek, L. M. & Russell, D. W. Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks. Mol. Cell. Biol. 23, 3550–3557 (2003). This study shows the augmentation of gene-targeting frequencies by the introduction of a DSB in the genomic target.
Porteus, M. H., Cathomen, T., Weitzman, M. D. & Baltimore, D. Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks. Mol. Cell. Biol. 23, 3558–3565 (2003). Published back-to-back with reference 63, this study confirmed the enhancement of gene targeting by DSBs in live cells by monitoring GFP repair.
Hauck, B., Zhao, W., High, K. & Xiao, W. Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction. J. Virol. 78, 13678–13686 (2004).
Yang, H., Li, Q., Fan, J., Holloman, W. K. & Pavletich, N. P. The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA–ssDNA junction. Nature 433, 653–657 (2005).
Forget, A. L., Bennett, B. T. & Knight, K. L. Xrcc3 is recruited to DNA double strand breaks early and independent of Rad51. J. Cell. Biochem. 93, 429–436 (2004).
Liu, Y., Masson, J. Y., Shah, R., O'Regan, P. & West, S. C. RAD51C is required for Holliday junction processing in mammalian cells. Science 303, 243–246 (2004).
Johnson, R. D. & Jasin, M. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. EMBO J. 19, 3398–3407 (2000).
Johnson, R. D. & Jasin, M. Double-strand-break-induced homologous recombination in mammalian cells. Biochem. Soc. Trans. 29, 196–201 (2001).
White, S. J. et al. Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors. Circulation 109, 513–519 (2004).
Ried, M. U., Girod, A., Leike, K., Buning, H. & Hallek, M. Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors. J. Virol. 76, 4559–4566 (2002).
Kohli, M., Rago, C., Lengauer, C., Kinzler, K. W. & Vogelstein, B. Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res. 32, e3 (2004).
Cummins, J. M. et al. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428, 1 p following 486 (2004).
Cummins, J. M. et al. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res. 64, 3006–3008 (2004).
Samuels, Y. et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561–573 (2005).
Goncalves, M. A. et al. Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability. J. Virol. 79, 3146–3162 (2005).
During, M. J., Kaplitt, M. G., Stern, M. B. & Eidelberg, D. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum. Gene Ther. 12, 1589–1591 (2001).
Song, S. et al. Recombinant adeno-associated virus-mediated α-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther. 11, 181–186 (2004).
Manno, C. S. et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101, 2963–2972 (2003).
Flotte, T. R. et al. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum. Gene Ther. 14, 1079–1088 (2003).
Chamberlain, J. R. et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303, 1198–1201 (2004). The closest to 'the clinic' that gene therapy with rAAV targeting vectors has reached to date.
Baksh, D., Song, L. & Tuan, R. S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J. Cell. Mol. Med. 8, 301–316 (2004).
Mallucci, G. & Collinge, J. Rational targeting for prion therapeutics. Nature Rev. Neurosci. 6, 23–34 (2005).
Hirata, R. K. et al. Efficient PRNP gene targeting in bovine fibroblasts by adeno-associated virus vectors. Cloning Stem Cells 6, 31–36 (2004). Shows the potential of the rAAV gene-targeting approach to generate cattle resistant to the prion disease BSE.
Szostak, J. W., Orr-Weaver, T. L., Rothstein, R. J. & Stahl, F. W. The double-strand-break repair model for recombination. Cell 33, 25–35 (1983).
Krogh, B. O. & Symington, L. S. Recombination proteins in yeast. Annu. Rev. Genet. 38, 233–271 (2004).
Acknowledgements
We thank Dr R. M. Linden for discussion.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Related links
DATABASES
Entrez
Swiss-Prot
CDC Infectious Disease Information
FURTHER INFORMATION
Glossary
- VECTORS
-
Nucleic-acid sequences derived from bacterial plasmids or viruses, used for delivery of exogenous DNA or RNA into cells.
- TRANSGENE
-
Artificially reconstituted gene, which can be expressed either pre- or post-integration into the genome; often encodes a therapeutic or a marker gene.
- SILENCING
-
In this context, complete or partial shut-off of transgene expression owing to factors acting at the locus of vector integration and/or the structure of the locus.
- HOMOLOGOUS RECOMBINATION
-
(HR). Substitution (reciprocal exchange or replacement) of a segment of DNA by another that is identical (homologous). Occurs naturally during meiotic recombination and DNA repair.
- NON-HOMOLOGOUS END JOINING
-
(NHEJ). Process of joining two broken DNA ends on the basis of limited or no homology between two DNA molecules, which can result in incorrect recovery of the sequence of a broken DNA molecule. Also functions to create genetic diversity during immune development.
- ISOGENIC
-
Genetically identical (except for sex).
- TRANSDUCTION
-
In this context, equivalent to infection with a virus used as a gene-therapy vector.
- EPISOME
-
Non-integrated, circular, double-stranded DNA molecule with the capacity to integrate into the chromosome of the host cell.
- TRANS-SPLICING
-
A reconstruction of a larger transcript by joining the 5′ and 3′ portions of a transcript from two independent viruses (co-adminstered to the same tissue) that have formed intermolecular concatemers.
- MULTIPLICITY OF INFECTION
-
Synonym of virus load, the number of viral particles or infectious units per infected cell. Usually represented by the number of viral genomes — gcp/cell (genome-containing particles per cell) or TU/cell (transducing units per cell).
- ETOPOSIDE
-
A chemical agent that blocks topoisomerase and therefore introduces random DNA breaks, which results in S-phase arrest.
- HYDROXYUREA
-
Causes depletion of the dNTP pool by inhibition of ribonucleotide reductase and thereby stalls DNA replication. Removal of hydroxyurea might stimulate viral second-strand synthesis.
- TYPE I COLLAGEN
-
The most abundant protein in vertebrates, and a constituent of the extracellular matrix in the connective tissue of bone, skin, tendon, ligament and dentine. It is produced and secreted mostly by fibroblasts and osteoblasts.
- GENE CONVERSION
-
A non-reciprocal transfer of genetic information.
- OSTEOGENESIS IMPERFECTA
-
The most common and the mildest form of a group of rare disorders affecting the connective tissue, which are characterized by fragile bones that fracture easily (brittle bones).
Rights and permissions
About this article
Cite this article
Vasileva, A., Jessberger, R. Precise hit: adeno-associated virus in gene targeting. Nat Rev Microbiol 3, 837–847 (2005). https://doi.org/10.1038/nrmicro1266
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrmicro1266
- Springer Nature Limited
This article is cited by
-
Contribution of yeast models to virus research
Applied Microbiology and Biotechnology (2021)
-
A non-invasive far-red light-induced split-Cre recombinase system for controllable genome engineering in mice
Nature Communications (2020)
-
Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adeno-associated viruses
Nature Communications (2018)
-
AAV-based dual-reporter circuit for monitoring cell signaling in living human cells
Journal of Biological Engineering (2017)
-
SgRNA Expression of CRIPSR-Cas9 System Based on MiRNA Polycistrons as a Versatile Tool to Manipulate Multiple and Tissue-Specific Genome Editing
Scientific Reports (2017)